Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
103703
Canadian Institutes of Health Research - Canada
106469
Canadian Institutes of Health Research - Canada
64410
Canadian Institutes of Health Research - Canada
PubMed
24331546
DOI
10.1016/j.biopsych.2013.11.007
PII: S0006-3223(13)00988-8
Knihovny.cz E-resources
- Keywords
- Bipolar disorder, Global assessment of functioning, N-acetylaspartate, Prefrontal cortex, Total creatine, Type 2 diabetes mellitus,
- MeSH
- Bipolar Disorder complications metabolism MeSH
- Diabetes Mellitus, Type 2 complications metabolism MeSH
- Adult MeSH
- Creatine metabolism MeSH
- Aspartic Acid analogs & derivatives metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Spectroscopy MeSH
- Brain metabolism MeSH
- Cross-Sectional Studies MeSH
- Psychiatric Status Rating Scales MeSH
- Risk Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Creatine MeSH
- Aspartic Acid MeSH
- N-acetylaspartate MeSH Browser
BACKGROUND: Neuroimaging changes in bipolar disorder (BD) may be secondary to the presence of certain clinical factors. Type 2 diabetes mellitus (T2DM) damages the brain and frequently co-occurs with BD. Studying patients with both T2DM and BD could help identify preventable risk factors for neuroimaging changes in BD. METHODS: We used 1.5T magnetic resonance spectroscopy to measure prefrontal N-acetylaspartate (NAA), which is mainly localized in neurons, and total creatine (tCr), an energy metabolite, in 19 BD patients with insulin resistance/glucose intolerance (BD + IR/GI), 14 BD subjects with T2DM (BD + T2DM), 15 euglycemic BD participants, and 11 euglycemic, nonpsychiatric control. RESULTS: The levels of NAA and tCr were lowest among BD + T2DM, intermediate in the BD + IR/GI, and highest among the euglycemic BD and control subjects (F₃,₅₅ = 4.57, p = .006; F₃,₅₅ = 2.92, p = .04, respectively). Even the BD + IR/GI subjects had lower NAA than the euglycemic participants (t₄₃ = 2.13, p = .04). Total Cr was associated with NAA (β = .52, t₅₆ = 5.57, p = .000001). Both NAA and tCr correlated with Global Assessment of Functioning scores (r₄₆ = .28, p = .05; r₄₆ = .48, p = .0004, respectively). CONCLUSIONS: T2DM, but also prediabetes, may be risk factors for prefrontal neurochemical alterations in BD. These changes were associated with poor psychosocial functioning and could indicate impaired energy metabolism. The findings emphasize the importance of improving diabetes care in BD and suggest potential options for treatment of neuroimaging alterations.
References provided by Crossref.org
Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders